Exact Sciences Corp. Files 8-K with Board and Compensation Updates
Ticker: EXAS · Form: 8-K · Filed: 2025-06-16T00:00:00.000Z
Sentiment: neutral
Topics: board-changes, executive-compensation, corporate-governance
TL;DR
Exact Sciences board shakeup & comp changes filed. Watch for strategic shifts.
AI Summary
Exact Sciences Corp. announced on June 12, 2025, changes in its board of directors and executive compensation arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits. Specific details regarding the departures, elections, appointments, and compensatory arrangements are provided within the document.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial performance, impacting investor confidence and future business direction.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect future performance or strategy.
Key Players & Entities
- EXACT SCIENCES CORP (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 001-35092 (company_id) — SEC File Number
- 204782291 (company_id) — EIN
- 5505 Endeavor Lane, Madison, WI 53719 (address) — Principal Executive Offices
- June 12, 2025 (date) — Date of earliest event reported
FAQ
What specific items were reported under the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' section?
The filing indicates that there were changes related to the departure of directors, election of directors, appointment of certain officers, and details on compensatory arrangements for certain officers.
What is the significance of the 'Submission of Matters to a Vote of Security Holders' item?
This item signifies that the company has submitted certain matters for a vote by its shareholders, which could include proposals on corporate governance, executive compensation, or other significant business decisions.
What types of documents are included as 'Financial Statements and Exhibits' in this filing?
The filing states that financial statements and exhibits are included, which typically contain audited financial reports, pro forma information, and other supporting documents relevant to the reported events.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 12, 2025.
What is Exact Sciences Corp.'s principal executive office address?
Exact Sciences Corp.'s principal executive office is located at 5505 Endeavor Lane, Madison, WI 53719.
From the Filing
0001124140-25-000046.txt : 20250616 0001124140-25-000046.hdr.sgml : 20250616 20250616080100 ACCESSION NUMBER: 0001124140-25-000046 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250612 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250616 DATE AS OF CHANGE: 20250616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 251048568 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20250612.htm 8-K exas-20250612 0001124140 false 0001124140 2025-06-12 2025-06-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  June 12, 2025   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02.                       Departure of Directors or Certain Offi